Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jing-Hua Tang"'
Autor:
Ding-Xin Liu, Dan-Dan Li, Wan He, Chuan-Feng Ke, Wu Jiang, Jing-Hua Tang, Ling-Heng Kong, Yuan Li, Qiao-Qi Sui, Bin-Yi Xiao, Wei-Rong Li, Zhi-Gang Hong, Rui-Hua Xu, Zhi-Zhong Pan, Xiao-Shi Zhang, Pei-Rong Ding
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Background: Although PD-1 blockade has significantly improved the survival of metastatic colorectal cancer with DNA Mismatch Repair-Deficient/Microsatellite Instability-High (MSI-H), the data on neoadjuvant setting is limited. Methods: In this retros
Externí odkaz:
https://doaj.org/article/fe1b1a39c56f48fb8aff60d008ee799e
Autor:
Qiao-Xuan Wang, Bin-Yi Xiao, Yong Cheng, Ai-Wen Wu, Tao Zhang, Hui Wang, Xuan Zhang, Wei-Xin Huang, Jing-Hua Tang, Wu Jiang, Scott R. Steele, Smitha Krishnamurthi, Yuan Li, Jian Cai, Ling-Heng Kong, Dan-Dan Li, Zhi-Zhong Pan, Xiao-Shi Zhang, Pei-Rong Ding
Publikováno v:
European Journal of Cancer. 174:176-184
In a portion of patients with DNA mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) rectal cancer, clinical complete response (cCR) could be achieved after anti-programmed cell death protein 1 (anti-PD-1) immunotherapy. However
Autor:
Kai Han, Jing-Hua Tang, Le-En Liao, Wu Jiang, Qiao-Qi Sui, Bin-Yi Xiao, Wei-Rong Li, Zhi-Gang Hong, Yuan Li, Ling-Heng Kong, Dan-Dan Li, Xiao-Shi Zhang, Zhi-Zhong Pan, Steele, Scott R., Pei-Rong Ding
Publikováno v:
Diseases of the Colon & Rectum; Oct2023, Vol. 66 Issue 10, pe996-e1005, 10p
Autor:
Wei-Jian Mei, Xiao-Zhong Wang, Yun-Feng Li, Yue-Ming Sun, Chun-Kang Yang, Jun-Zhong Lin, Zu-Guang Wu, Rui Zhang, Wei Wang, Yong Li, Ye-Zhong Zhuang, Jian Lei, Xiang-Bin Wan, Ying-Kun Ren, Yong Cheng, Wen-Liang Li, Zi-Qiang Wang, Dong-Bo Xu, Xian-Wei Mo, Hai-Xing Ju, Sheng-Wei Ye, Jing-Lin Zhao, Hong Zhang, Yuan-Hong Gao, Zhi-Fan Zeng, Wei-Wei Xiao, Xiao-Peng Zhang, Xuan Zhang, E Xie, Yi-Fei Feng, Jing-Hua Tang, Xiao-Jun Wu, Gong Chen, Li-Ren Li, Zhen-Hai Lu, De-Sen Wan, Jin-Xin Bei, Zhi-Zhong Pan, Pei-Rong Ding
Publikováno v:
Annals of surgery.
To compare neoadjuvant chemotherapy (nCT) with CAPOX alone versus neoadjuvant chemoradiotherapy (nCRT) with capecitabine in locally advanced rectal cancer (LARC) with uninvolved mesorectal fascia (MRF).nCRT is associated with higher surgical complica
Autor:
Kai, Han, Jing-Hua, Tang, Le-En, Liao, Wu, Jiang, Qiao-Qi, Sui, Bin-Yi, Xiao, Wei-Rong, Li, Zhi-Gang, Hong, Yuan, Li, Ling-Heng, Kong, Dan-Dan, Li, Xiao-Shi, Zhang, Zhi-Zhong, Pan, Scott R, Steele, Pei-Rong, Ding
Publikováno v:
Diseases of the Colon & Rectum.
Colorectal cancer patients with mismatch repair deficiency are usually less aggressive and associated with lower risk of distant metastasis. Immune checkpoint inhibition, rather than traditional chemoradiotherapy, has shown great advantages in treati
Autor:
Bin-Yi Xiao, Xuan Zhang, Tai-Yuan Cao, Dan-Dan Li, Wu Jiang, Ling-Heng Kong, Jing-Hua Tang, Kai Han, Chen-Zhi Zhang, Wei-Jian Mei, Jian Xiao, Zhi-Zhong Pan, Yun-Feng Li, Xiao-Shi Zhang, Pei-Rong Ding
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:60-66.e5
Background: Our study aimed to evaluate the efficacy and feasibility of neoadjuvant anti–PD-1 treatment for localized mismatch repair–deficient (dMMR) colorectal cancer (CRC). Patients and Methods: The study cohort included patients with localize
Autor:
Wu Jiang, Lin Li, Chuan-Feng Ke, Wei Wang, Bin-Yi Xiao, Ling-Heng Kong, Jing-Hua Tang, Yuan Li, Xiao-Dan Wu, Ying Hu, Wei-Hua Guo, Si-Zhen Wang, De-Sen Wan, Rui-Hua Xu, Zhi-Zhong Pan, Pei-Rong Ding
Publikováno v:
Journal of Medical Genetics; Apr2022, Vol. 59 Issue 4, p370-376, 7p
Autor:
Xin An, Pei-Rong Ding, Yuanhong Gao, Xi Lin, Zhizhong Pan, Guo Chen Liu, Jing Hua Tang, Ling Heng Kong
Publikováno v:
Oncotarget
// Jing-Hua Tang 1, 2, * , Xin An 1, 3, * , Xi Lin 1, 4, * , Yuan-Hong Gao 1, 5 , Guo-Chen Liu 1, 2 , Ling-Heng Kong 1, 2 , Zhi-Zhong Pan 1, 2 , Pei-Rong Ding 1, 2 1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for
Autor:
Jing Hua Tang, Wei Jiang Sun, Jun Zhong Lin, Gong Chen, Yuanhong Gao, Guo Chen Liu, Juan Cai, Ling Heng Kong, Xin An, Pei Rong Ding, Mu Yan Cai, Xiao Jun Wu, Zhi Zhong Pan
Publikováno v:
Journal of Surgical Oncology. 109:478-482
Background and Objectives Systemic failure remains a predominant issue in locally advanced rectal cancer (LARC). A new strategy using capecitabine and oxaliplatin (XELOX regimen) administered prior to and then concomitant to radiotherapy for high ris
Autor:
Xin An, Zhizhong Pan, Pei Qiang Cai, Li Ren Li, Ling Heng Kong, Jun Zhong Lin, Jing Hua Tang, Guo Chen Liu, Shu Juan Wen, Hua Xiang Cao, Pei-Rong Ding
Publikováno v:
Journal of Surgical Oncology. 108:568-571
Background and Objectives This analysis aims to evaluate the value of early surveillance within 6 months after resection for stage II/III colorectal cancer (CRC). Methods Patients with stage II/III CRC who received surgery with curative intent for CR